Labiotech.eu (blog) [1] |
Broken Promises: Adocia Takes Eli Lilly to Court for Ditching its Diabetes Treatment [1]
Labiotech.eu (blog) Adocia is unhappy with Eli Lilly, which walked away from their diabetes collaborations, which has left the biotech without a Phase III partner. Not long ago, they were working together to produce new diabetes treatments but now the relationship between … Adocia demands $200 million for Lilly's alleged diabetes deal breaches [2]The Pharma Letter Financial Newsletter – Zacks [3]Zacks Eli Lilly And Company – LLY – Stock Price Today – Zacks [4]Zacks SEC.gov [5] all 46 news articles » [6] |
More details can be found at www.diabeteshowto.com [7]